Pharmacogenomic screening for anthracycline-induced cardiotoxicity in childhood cancer

by Aminkeng, Folefac, Ross, Colin JD, Rassekh, Shahrad R, Rieder, Michael J, Bhavsar, Amit P, Sanatani, Shubhayan, Bernstein, Daniel, Hayden, Michael R, Amstutz, Ursula, Carleton, Bruce C
Published 2022

Predicting Anthracycline-induced Cardiotoxicity in Children - Genome-Wide Association Study

by Aminkeng, Folefac, Ross, Colin JD, Rassekh, Rod S, Brunham, Liam R, Weissman, Cory, Dube, Marie-Pierre, Visscher, Henk, Rieder, Michael J, Carleton, Bruce C, Hayden, Michael R
Published 2022

Recommendations for genetic testing to reduce the incidence of anthracycline-induced cardiotoxicity

by Aminkeng, Folefac, Ross, Colin JD, Rassekh, Shahrad R, Hwang, Soomi, Rieder, Michael J, Bhavsar, Amit P, Smith, Anne, Sanatani, Shubhayan, Gelmon, Karen A, Bernstein, Daniel, Hayden, Michael R, Amstutz, Ursula, Carleton, Bruce C
Published 2022

A coding variant in RARG confers susceptibility to anthracycline-induced cardiotoxicity in childhood cancer

by Aminkeng, Folefac, Bhavsar, Amit P, Visscher, Henk, Rassekh, Shahrad R, Li, Yuling, Lee, Jong W, Brunham, Liam R, Caron, Huib N, van Dalen, Elvira C, Kremer, Leontien C, van der Pal, Helena J, Amstutz, Ursula, Rieder, Michael J, Bernstein, Daniel, Carleton, Bruce C, Hayden, Michael R, Ross, Colin JD
Published 2022

CYP2D6 as a treatment decision aid for ER-positive non-metastatic breast cancer patients: a systematic review with accompanying clinical practice guidelines

by Drogemoller, Britt I, Wright, Galen EB, Shih, Joanne, Monzon, Jose G, Gelmon, Karen A, Ross, Colin JD, Amstutz, Ursula, Carleton, Bruce C, Chang, Wan C, Connolly, Mary B, Dionne, Francois, Groeneweg, Gabriella, Loucks, Catrina M, MacLeod, Stuart M, Pritchard, Sheila, Rassekh, Shahrad R, Sanatani, Shubhayan, Bhavsar, Amit P, Rieder, Michael J, Shear, Neil H, Ito, Shinya, Liu, Geoffrey, Khayat, Philip, Bernstein, Daniel, Lesko, Lawrence J, Aminkeng, Folefac
Published 2022